California researchers seek more than 130 people to participate in four upcoming clinical studies involving cannabis, including a study with children.
The studies, to be conducted by the University of California, San Diego (UCSD) Center for Medicinal Cannabis Research will focus on the use of cannabinoids as a treatment for anorexia nervosa, autism, essential tremor, and schizophrenia, and are all expected to launch in 2019. The four studies will be conducted separately and will run for different durations.
The university will be examining the effectiveness of cannabidiol (CBD) in the reduction of symptoms and improvement of cognitive abilities in people diagnosed with schizophrenia. The clinical trial will also look into how CBD affects the response to stress and eating behaviors in people on antipsychotic medication.
The clinical trial would involve 78 adults who have been recently